<p>Preprints – versions
of manuscripts posted on public servers before formal peer review – are shaking
up the world of bioscience publishing, and they have been crucial during the
COVID-19 pandemic for sharing results rapidly and widely. However, despite
their benefits, the use of preprint servers for sharing pharma-funded research
remains low. </p><p><br></p>
<p>To address this
issue, we have created a new educational resource that explores how and why
preprint servers are a valuable tool for disseminating pharma research. The resource
covers:</p>
<p>·
the
different types of preprint servers available</p>
<p>·
the
benefits of sharing pharma research before peer review</p>
<p>·
the
potential risks of sharing pharma research through preprint servers and how to
mitigate them.</p>